Casey):  S. 477. A bill to amend the Public Health Service Act to coordinate Federal congenital heart disease research and surveillance efforts and to improve public education and awareness of congenital heart disease, and for other purposes; to the Committee on Health, Education, Labor, and Pensions.                                 S. 477       Be it enacted by the Senate and House of Representatives of      the United States of America in Congress assembled,     SECTION 1. SHORT TITLE.       This Act may be cited as the ``Congenital Heart Futures      Reauthorization Act of 2017''.     SEC. 2. NATIONAL CONGENITAL HEART DISEASE COHORT STUDY,                    SURVEILLANCE, AND AWARENESS CAMPAIGN.       Section 399V-2 of the Public Health Service Act (42 U.S.C.      280g-13) is amended--       (1) by amending the section heading to read as follows:      ``NATIONAL CONGENITAL HEART DISEASE COHORT STUDY,      SURVEILLANCE SYSTEM, AND AWARENESS CAMPAIGN'';       (2) by amending subsection (a) to read as follows:       ``(a) In General.--       ``(1) Activities.--The Secretary shall--       ``(A) enhance and expand research and surveillance      infrastructure to study and track the epidemiology of      congenital heart disease (in this section referred to as      `CHD') across the lifespan; and       ``(B) plan and implement a public outreach and education      campaign regarding CHD across the lifespan.       ``(2) Grants.--The Secretary may award grants to eligible      entities to carry out the activities described in subsections      (b), (c), and (d).'';       (3) in subsection (b)--       (A) in the heading, by striking ``Purpose'' and inserting      ``National Congenital Heart Disease Surveillance System'';      and       (B) by striking ``The purpose of the Congenital Heart      Disease Surveillance System shall be to facilitate'' and      inserting the following:       ``(1) In general.--The Secretary shall establish a      Congenital Heart Disease Surveillance System for the purpose      of facilitating'';       (4) in subsection (c)--       (A) in paragraph (2), by redesignating subparagraphs (A)      through (E) as clauses (i) through (v), respectively, and      adjusting the margins accordingly;       (B) by redesignating paragraphs (1) through (3) as      subparagraphs (A) through (C), respectively, and adjusting      the margins accordingly; and       (C) by redesignating such subsection (c) as paragraph (2)      of subsection (b) and adjusting the margin accordingly;       (5) by striking subsections (d) and (e) and inserting the      following:       ``(c) National Congenital Heart Disease Cohort Study.--       ``(1) In general.--The Secretary, acting through the      Director of the Centers for Disease Control and Prevention,      shall plan, develop, implement, and submit annual reports to      the Congress on research and surveillance activities of the      Centers for Disease Control and Prevention, including a      cohort study to improve understanding of the epidemiology of      CHD across the lifespan, from birth to adulthood, with      particular interest in the following:       ``(A) Health care utilization and natural history of      individuals affected by CHD.       ``(B) Demographic factors associated with CHD, such as age,      race, ethnicity, gender, and family history of individuals      who are diagnosed with the disease.       ``(C) Outcome measures, such that analysis of the outcome      measures will allow derivation of evidence-based best      practices and guidelines for CHD patients.       ``(2) Permissible considerations.--The study under this      subsection may--       ``(A) gather data on the health outcomes of a diverse      population of those affected by CHD;       ``(B) consider health disparities among those affected by      CHD which may include the consideration of prenatal      exposures; and       ``(C) incorporate behavioral, emotional, and educational      outcomes of those affected by CHD.       ``(3) Public access.--Subject to appropriate protections of      personal information, including protections required under      paragraph (4), data generated from the study under this      subsection and through the Congenital Heart Disease      Surveillance System under subsection (b) shall be made      available for purposes of CHD research and to the public.       ``(4) Patient privacy.--The Secretary shall ensure that the      study under this subsection and the Congenital Heart Disease      Surveillance System under subsection (b) are carried out in a      manner that complies with the requirements applicable to a      covered entity under the regulations promulgated pursuant to      section 264(c) of the Health Insurance Portability and      Accountability Act of 1996.       ``(d) Congenital Heart Disease Awareness Campaign.--       ``(1) In general.--The Secretary, acting through the      Director of the Centers for Disease Control and Prevention,      shall establish and implement an awareness, outreach, and      education campaign regarding CHD across the lifespan. The      information expressed through such campaign may--       ``(A) emphasize the prevalence of CHD;       ``(B) identify CHD as a condition that affects those      diagnosed throughout their lives; and       ``(C) promote the need for pediatric, adolescent, and adult      individuals with CHD to seek and maintain lifelong,      specialized care.       ``(2) Permissible activities.--The campaign under this      subsection may--       ``(A) utilize collaborations or partnerships with other      agencies, health care professionals, and patient advocacy      organizations that specialize in the needs of individuals      with CHD; and       ``(B) include the use of print, film, or electronic      materials distributed via television, radio, Internet, or      other commercial marketing venues.'';       (6) by redesignating subsection (f) as subsection (e); and       (7) by adding at the end the following:       ``(f) Authorization of Appropriations.--To carry out this      section, there are authorized to be appropriated such sums as      may be necessary for each of fiscal years 2017 through      2021.''.       SEC. 3. CONGENITAL HEART DISEASE RESEARCH.       Section 425 of the Public Health Service Act (42 U.S.C.      285b-8) is amended by adding the end the following:       ``(d) Report From NIH.--Not later than 1 year after the      date of enactment of the Congenital Heart Futures      Reauthorization Act of 2017, the Director of NIH, acting      through the Director of the Institute, shall provide a report      to Congress--       ``(1) outlining the ongoing research efforts of the      National Institutes of Health regarding congenital heart      disease; and       ``(2) identifying--       ``(A) future plans for research regarding congenital heart      disease; and       ``(B) the areas of greatest need for such research.''.                          ____________________